When one door closes, another door opens … for some: Evidence from the post-TRIPS Indian pharmaceutical industry

Keyphrases

• Area of Expertise 25%
• Contextual Change 25%
• Decision Frames 25%
• Firm Profitability 25%
• Firm Strategy 25%
• Generic Drugs 50%
• India 25%
• Indian Pharmaceutical Firms 50%
• Indian Pharmaceutical Industry 100%
• Institutional Context 25%
• Intellectual Property Regimes 75%
• IP Regimes 25%
• Knowledge Assets 25%
• Knowledge Base 50%
• Knowledge Scope 25%
• Legal Protection 50%
• New IP 25%
• New Product Development 50%
• Novel Innovation 25%
• Patent Enforcement 25%
• Process-based 25%
• Product Patent 25%
• Regime Shift 25%
• Strategic Choice 75%
• Strategic Opportunities 25%
• Strategy Choice 25%
• T-shaped 25%
• Technological Change 25%
• Trade-related Aspects of Intellectual Property Rights (TRIPS) 100%

Social Sciences

• Brand Name 50%
• Firm Strategy 25%
• Framing 25%
• India 25%
• Institutional Context 25%
• Intellectual Property Right 100%
• Legal Protection 50%
• Pharmaceutical Industry 100%
• Simultaneous Engineering 50%

Economics, Econometrics and Finance

• Brand Name 50%
• Firm Strategy 25%
• Institutional Context 25%
• Intellectual Property Right 100%
• New Product Development 50%
• Pharmaceutical Industry 100%
• Workforce 25%